Trial intelligence / Profile preview

N-acetylcysteine to prevent postoperative atrial fibrillation after cardiac surgery

IRCT201008134561N1Phase 2Completed

Sponsor
Cardiovascular Research Center, Tabriz University of Medical Sciences
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of acetylcysteine in Atrial fibrillation (AFib) (2 arms), sponsored by Cardiovascular Research Center, Tabriz University of Medical Sciences. Started Apr 2010; status: completed.

02

Drugs

acetylcysteine
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on IRCT201008134561N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201008134561N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call